epinephrine and hemostat powder in burn

Comparing the effectiveness of epinephrine and hemostat powder on the prevention of bleeding during burn debridement

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230517058217N1

Enrollment

108

Registered

2023-06-01

Start date

2023-09-23

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn. burn

Interventions

Intervention 1: Intervention group: Hemostat powder. Intervention 2: Control group: Diluted epinephrine.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Thermal burn patients with total body surface area (TBSA) involvement less than 30%

Exclusion criteria

Exclusion criteria: Coagulopathies Active malignancies Autoimmune diseases Patients who receive corticosteroids daily

Design outcomes

Primary

Measure	Time frame
Hemoglobin drop rate. Timepoint: Six hours before surgery and six hours after surgery. Method of measurement: Venous sampling from the brachial vein.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohamad Sabouri

Zanjan University of Medical Sciences

dr.m.sabourii@gmail.com+98 21 8806 4148

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026